| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/2014 | US8710326 Maize variety inbred PH1CD7 |
| 04/29/2014 | US8710325 Maize variety X00C175 |
| 04/29/2014 | US8710312 Maize variety hybrid X03A157 |
| 04/29/2014 | US8710296 Defensin polynucleotides and methods of use |
| 04/29/2014 | US8710205 Transcription factor |
| 04/29/2014 | US8710202 Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity |
| 04/29/2014 | US8710197 High pressure refolding of protein aggregates and inclusion bodies |
| 04/29/2014 | US8710195 Fluorescent proteins |
| 04/29/2014 | US8710188 Factor IXa crystals, related complexes and methods |
| 04/29/2014 | US8710187 Modified binding proteins inhibiting the VEGF-A receptor interaction |
| 04/29/2014 | US8710186 Taste receptors of the T1R family from domestic cat |
| 04/29/2014 | US8710185 Bacterial superantigen vaccines |
| 04/29/2014 | US8710184 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| 04/29/2014 | US8710180 VEGF-specific capture agents, compositions, and methods of using and making |
| 04/29/2014 | US8710025 Modified and stabilized GDF propeptides and uses thereof |
| 04/29/2014 | US8710017 Human and mouse targeting peptides identified by phage display |
| 04/29/2014 | US8710016 ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
| 04/29/2014 | US8710015 Tropoelastin derivatives |
| 04/29/2014 | US8710014 Compositions and methods for inhibition of MMP13:MMP-substrate interactions |
| 04/29/2014 | US8710009 HSP20 inhibits amyloidogenesis and neurotoxicity |
| 04/29/2014 | US8710008 Compounds, compositions and use |
| 04/29/2014 | US8710007 Prevention and reduction of blood loss |
| 04/29/2014 | US8710005 Neuronal differentiation-inducing peptide and use thereof |
| 04/29/2014 | US8709998 Peptide vectors |
| 04/29/2014 | US8709813 DNA promoters and anthrax vaccines |
| 04/29/2014 | US8709779 Newly identified human rhinovirus of HRV-C and methods and kits for detecting HRV-Cs |
| 04/29/2014 | US8709759 Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins |
| 04/29/2014 | US8709758 Methods and compositions for inhibition of neutrophil exocytosis |
| 04/29/2014 | US8709757 Method for producing interferon alpha 5 |
| 04/29/2014 | US8709752 Process for producing dipeptides or dipeptide derivatives |
| 04/29/2014 | US8709737 Bitter taste receptors |
| 04/29/2014 | US8709734 Method for identifying modulators of GPCR GPR1 function |
| 04/29/2014 | US8709710 Methods of modulating interleukin-22 and immune response by notch regulators |
| 04/29/2014 | US8709492 Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals |
| 04/29/2014 | US8709442 Recombinant negative strand virus RNA expression systems and vaccines |
| 04/29/2014 | US8709441 TC-83-derived alphavirus vectors, particles and methods |
| 04/29/2014 | US8709437 Clostridium chauvoei polypeptide, DNA encoding the polypeptide and a vaccine comprising the polypeptide |
| 04/29/2014 | US8709427 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form |
| 04/29/2014 | US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/29/2014 | US8709425 Antibodies to non-functional P2X7 receptor |
| 04/29/2014 | US8709405 Cancer vaccines containing epitopes of oncofetal antigen |
| 04/29/2014 | CA2551916C Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 04/29/2014 | CA2550361C Compounds and methods for development of ret modulators |
| 04/29/2014 | CA2534907C Homogeneous preparations of il-28 and il-29 |
| 04/29/2014 | CA2493124C Vaccine |
| 04/29/2014 | CA2481556C Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 04/29/2014 | CA2472381C Glycosyltransferase gnt-v having neovascularization action |
| 04/29/2014 | CA2462946C Recombinant p. falciparum merozoite protein-142 vaccine |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/29/2014 | CA2232048C Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 04/24/2014 | WO2014063097A1 Stabilization of biomimetic membranes |
| 04/24/2014 | WO2014062134A1 Compounds and methods for the production of suckerin and uses thereof |
| 04/24/2014 | WO2014062069A1 Shon as a prognostic biomarker for cancer and as a predictor of response to endocrine therapy |
| 04/24/2014 | WO2014061749A1 Synthetic peptide capable of suppressing expression of tnf receptor type-2, and use thereof |
| 04/24/2014 | WO2014060898A2 Compositions and methods relating to a mutant clostridium difficile toxin |
| 04/24/2014 | WO2014060623A1 Functionalised and immunoreactive derivatives for the fungicide fludioxonil |
| 04/24/2014 | WO2014060610A2 Antimicrobial peptides |
| 04/24/2014 | WO2014060606A1 Alpha- and gamma-msh analogues |
| 04/24/2014 | WO2014060601A1 Compositions and methods for drug delivery |
| 04/24/2014 | WO2014060594A1 Production of a hcmv based vaccine in human amniocyte cell lines |
| 04/24/2014 | WO2014060580A1 Lxvp-mediated calcineurin inhibition in macrophages |
| 04/24/2014 | WO2014060517A1 Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (amd) |
| 04/24/2014 | WO2014060514A1 Novel recombinant bordetella strains |
| 04/24/2014 | WO2014060452A1 A thermostable sucrose and sucrose-6'-phosphate phosphorylase |
| 04/24/2014 | WO2014060385A1 Immunogenic composition |
| 04/24/2014 | WO2014060383A1 Immunogenic composition comprising 1 or more streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising protein e and/or pila fromhaemophilus influenzae. |
| 04/24/2014 | WO2014060365A1 Bispecific her2 ligands for cancer therapy |
| 04/24/2014 | WO2014060109A1 Gene therapy for glycogen storage diseases |
| 04/24/2014 | WO2014059789A1 Asparaginic acid kinase iii mutant and host cells and use thereof |
| 04/24/2014 | WO2014059544A1 Transgenic cells for identifying gpcr signaling compound modulating gpcr signaling pathway and screening method thereof |
| 04/24/2014 | WO2014059541A1 Novel cell wall deconstruction enzymes of thermoascus aurantiacus, myceliophthora fergusii (corynascus thermophilus), and pseudocercosporella herpotrichoides, and uses thereof |
| 04/24/2014 | WO2014059530A1 Derivatives of collagen-binding hairpin peptides |
| 04/24/2014 | WO2014040025A3 Immunogens of hiv-1 broadly neutralizing antibodies, methods of generation and uses thereof |
| 04/24/2014 | WO2012125730A3 Reactor systems |
| 04/24/2014 | US20140113960 Modified polynucleotides encoding granulysin |
| 04/24/2014 | US20140113959 Modified polynucleotides encoding caspase 6 |
| 04/24/2014 | US20140113871 Modification of Peptides via SNAr Reactions of Thiols with Fluorinated Aromatics |
| 04/24/2014 | US20140113860 Long-acting polypeptides and methods of producing and administering same |
| 04/24/2014 | US20140113858 Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof |
| 04/24/2014 | US20140113857 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9 |
| 04/24/2014 | US20140113854 Locally-Active Anticoagulants and Anti-Inflammatory Agents |
| 04/24/2014 | US20140113836 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid |
| 04/24/2014 | US20140113832 Engineered thioredoxin-like fold proteins |
| 04/24/2014 | US20140113376 Compositions and methods for downregulating prokaryotic genes |
| 04/24/2014 | US20140113370 Fc fusion proteins comprising novel linkers or arrangements |
| 04/24/2014 | US20140113367 Systems, Methods and Compositions for Optical Stimulation of Target Cells |
| 04/24/2014 | US20140113348 Meditopes and meditope-binding antibodies and uses thereof |
| 04/24/2014 | US20140113330 Modified vitamin k-dependent polypeptides |
| 04/24/2014 | US20140113329 High-cell density fed-batch fermentation process for producing recombinant protein |
| 04/24/2014 | US20140112949 Recombinant Mycobacterium Avium Subsp. Paratuberculosis Proteins Induce Immunity and Protect Against Infection |
| 04/24/2014 | US20140112948 Multi-Target Recombination Gene and the Application of its Protein to Prevent and Cure Helicobacter Pylori |
| 04/23/2014 | EP2722391A1 Method for plant improvement |
| 04/23/2014 | EP2722389A2 Method for enhancing the production yield of human papillomavirus l1 protein |
| 04/23/2014 | EP2722340A1 Alpha- and gamma-MSH analogues |
| 04/23/2014 | EP2722339A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation |
| 04/23/2014 | EP2722338A1 Novel recombinant Bordetella strains |
| 04/23/2014 | EP2722337A1 Production of a HCMV based vaccine in human amniocyte cell lines |
| 04/23/2014 | EP2722056A1 CT062, a Chlamydia antigen |
| 04/23/2014 | EP2721409A1 Materials and methods for determining sensitivity potential of compounds |
| 04/23/2014 | EP2721161A2 Methods of making nylon intermediates from glycerol |